Key result
Angiotensin II plus high salt synergistically drives systemic inflammation and alters cardiac resident macrophage phenotypes.
Why the study?
The role of genetic risk factors in acute decompensation of heart failure remains poorly understood. This study sought to identify the molecular pathways explaining detrimental cardiac adaptations to angiotensin II and high-salt diet in Balb/CJ mice compared with protected C57BL/6J mice.
Does treatment with angiotensin II and a high-salt diet induce systemic inflammation and alter cardiac gene expression and resident macrophage phenotype differently in Balb/CJ versus C57BL/6J mice?
Does treatment with angiotensin II and a high-salt diet induce systemic inflammation and alter cardiac gene expression and resident macrophage phenotype differently in Balb/CJ versus C57BL/6J mice?
This preclinical study demonstrates that angiotensin II combined with a high-salt diet synergistically drives systemic inflammation and alters cardiac resident macrophage phenotypes in mice, while genetic background (Balb/CJ vs C57BL/6J) determines susceptibility to acute heart failure decompensation.
Answers are grounded in this paper and cite their sources.
Strain-specific macrophage shifts under Ang II plus salt are hypothesis-generating in mice; leaves open human HF relevance.
Acute decompensation of heart failure is associated with high mortality and the role of genetic risk factors remain poorly understood. Balb/CJ mice rapidly decompensate following a treatment with angiotensin II and high-salt diet (AngII+Salt). They present with reduced cardiac output, peripheral edema, and high mortality while C57BL/6J are protected. The aim of this study was to identify molecular pathways that explain the detrimental cardiac adaptations in Balb/CJ compared to C57BL/6J mice. Both Balb/CJ and C57BL/6J mice showed signs of cardiac hypertrophy after treatment with AngII+Salt, whereas only Balb/CJ mice developed substantial pulmonary edema and reduced cardiac output. Cardiac gene expression was measured using microarrays in Sham, AngII, Salt and AngII+Salt treated Balb/CJ and C57BL/6J. Already at baseline, cardiac gene expression was significantly different between the strains. Following AngII and AngII+Salt treatment, angiotensin II was the main driver of cardiac gene expression. Enrichment analysis of genes containing SNPs and exhibiting differential expression following AngII, Salt or AngII+Salt treatment identified several immune-related pathways. Angiotensin II was the dominant driver of systemic inflammation in both strains, measured as plasma IL-6, IL-16 and CCL2. Interestingly, combining angiotensin II and high-salt diet exhibited a synergistic effect on systemic inflammation. AngII+Salt altered phenotype of cardiac resident macrophages in both strains without affecting immune cell infiltration. In conclusion, angiotensin II is the main driver of cardiac gene expression following AngII+Salt treatment which is associated with systemic inflammation and altered cardiac resident macrophage phenotype in both Balb/CJ mice and C57BL/6J mice.
No takes yet. Share an insight, caveat, or question.
Becirovic‐Agic et al. (2026) studied Acute decompensation of heart failure (mouse model). Angiotensin II and high-salt diet (AngII+Salt) vs. Sham, Angiotensin II alone, or high-salt diet alone (and comparison between Balb/CJ and C57BL/6J strains) was evaluated on Cardiac gene expression, systemic inflammation (plasma IL-6, IL-16, CCL2), and cardiac resident macrophage phenotype. Angiotensin II plus high-salt diet synergistically increased systemic inflammation (IL-6, IL-16, CCL2) and altered cardiac resident macrophage phenotypes in Balb/CJ and C57BL/6J mice.
Synapse has enriched 10 related papers. Consider them for comparative context: